Key facts about Eribulin Mesylate
What dosages is Eribulin Mesylate available in?
Eribulin Mesylate is available as 1 mg per 2 mL (0.5 mg per mL) of Eribulin Mesylate in a single-dose vial.
What is Eribulin Mesylate used for?
Eribulin Mesylate is a chemotherapy that’s used to treat cancers, such as metastatic breast cancer and liposarcoma (a type of soft tissue cancer).
How does Eribulin Mesylate work?
Eribulin Mesylate is a microtubule inhibitor. It works by stopping microtubules in the body’s cells from working. When the medication blocks the microtubules in cancer cells, the cells can’t grow as easily and can die off.
How do I take Eribulin Mesylate?
Administer 1.4 mg/m2 of Eribulin Mesylate intravenously over 2 to 5 minutes on Days 1 and 8 of a 21-day cycle.
Is it safe for me to take Eribulin Mesylate?
Eribulin Mesylate is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.
Eribulin Mesylate Common Side Effects
Common side effects of Eribulin Mesylate:
- Low blood cell counts
- Fatigue
- Hair loss
- Feeling numbness or tingling
- Nausea
- Constipation
Eribulin Mesylate Serious Side Effects
Serious side effects are rare with Eribulin Mesylate. Contact your healthcare provider immediately if you experience any of the following:
- Infections (as a result of having low white blood cell counts): fever, chills, cough, pain or burning when urinating
- Abnormal heart rhythms: new pounding or fluttering heartbeat, lightheadedness, dizziness, chest pain
Effects of other drugs, drug classes and over-the-counter products on Eribulin Mesylate
There are no major drug interactions listed for this medication. However, always let your physician and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking.
Who makes Eribulin Mesylate?
Various FDA-approved generic manufacturers
Is Eribulin Mesylate safe in pregnancy?
Eribulin Mesylate can harm your unborn baby. Tell your doctor right away if you become pregnant or think you are pregnant during treatment. Females who are able to become pregnant should use an effective birth control during treatment and for at least 2 weeks after the final dose. Males should use an effective form of birth control when having sex with female partners who are able to become pregnant during treatment and for 3 1/2 months (14 weeks) after the final dose.
